| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Hill Farm Research Station, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Rt. 1, Box 10, Homer 71040
Twenty-five Staphylococcus aureus strains isolated from bovine mastitis were tested for their susceptibility to ceftiofur. Zone diameter for 30 µg disks averaged 39 mm, and minimum inhibitory concentrations ranged from .5 to 1 µg/ml. Tissue and milk concentrations were determined from biopsy and quarter milk samples collected from eight cows treated with either intramammary infusion of 100 or 200 mg of ceftiofur, one or two intramuscular injections of 500 mg of ceftiofur, or combination therapy of intramammary infusion coupled with intramuscular injection. Three additional cows received two intramammary infusions of 200 mg of cephapirin at 24-h intervals. Intramuscular injections of ceftiofur resulted in tissue and milk concentrations below detectable limits. Staphylococcus aureus was not eliminated from infected mammary glands by infusion of 100 mg of ceftiofur or by injection of 500 mg of ceftiofur by 48 h after treatment. Combination therapy of 100 mg of ceftiofur infused and 500 mg injected reduced S. aureus numbers in milk and tissue markedly, as did infusion of 200 mg of ceftiofur. Cows receiving intramammary infusion of 200 mg of ceftiofur (two doses at 24-h intervals) had highest concentrations in milk (450 µg/ml at 4 and 6 h) and in tissue (.08 µg/mg at 30 h). These concentrations are similar to those obtained with two 200-mg doses of cephapirin at 24-h intervals. Histologic analysis of mammary parenchymal tissues showed that combination therapy resulted in higher percentages of alveolar luminal area and lower percentages of interalveolar stroma compared with infusion or injection alone. Histology of quarters receiving combination therapy was not different from that of quarters receiving cephapirin infusion alone.
Key Words: ceftiofur • antibiotic therapy • mastitis
Submitted on April 27, 1990
Accepted on July 9, 1990
This article has been cited by other articles:
|
|
 |
|
  M. D. Apparao, P. L. Ruegg, A. Lago, S. Godden, R. Bey, and K. Leslie Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium J Dairy Sci, June 1, 2009; 92(6): 2589 - 2597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pol and P. L. Ruegg Treatment Practices and Quantification of Antimicrobial Drug Usage in Conventional and Organic Dairy Farms in Wisconsin J Dairy Sci, January 1, 2007; 90(1): 249 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Wenz, F. B. Garry, J. E. Lombard, R. Elia, D. Prentice, and R. P. Dinsmore Short Communication: Efficacy of Parenteral Ceftiofur for Treatment of Systemically Mild Clinical Mastitis in Dairy Cattle J Dairy Sci, October 1, 2005; 88(10): 3496 - 3499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Erskine, P. C. Bartlett, J. L. VanLente, and C. R. Phipps Efficacy of Systemic Ceftiofur as a Therapy for Severe Clinical Mastitis in Dairy Cattle J Dairy Sci, October 1, 2002; 85(10): 2571 - 2575. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
